Recent human topical evidence A 2023 IRB-approved 21-woman topical trial of NEEL gel (a stabilized GHK-Cu topical) reported an average 28% increase in skin collagen density at 3 months, with a top quartile reporting 51%
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
Do not adjust the dose without consulting your physician
Infected diabetic wound healing After the infected diabetic wound model was established, droplets of hydrogel solution, including hydrogel, GHEA@Gel, RHEA@Gel, or G-RHEA@Gel, were added to the wound
PLoS One 18 , e0282063 (2023)
While clinical trial data supports its efficacy, adoption is still limited to tier-1 cities and private healthcare setups due to its premium pricing